JP2025520692A5 - - Google Patents
Info
- Publication number
- JP2025520692A5 JP2025520692A5 JP2024575463A JP2024575463A JP2025520692A5 JP 2025520692 A5 JP2025520692 A5 JP 2025520692A5 JP 2024575463 A JP2024575463 A JP 2024575463A JP 2024575463 A JP2024575463 A JP 2024575463A JP 2025520692 A5 JP2025520692 A5 JP 2025520692A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- acid sequence
- seq
- cancer
- fragment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNPCT/CN2022/100315 | 2022-06-22 | ||
| CN2022100315 | 2022-06-22 | ||
| PCT/CN2023/101761 WO2023246879A1 (en) | 2022-06-22 | 2023-06-21 | Anti-slc34a2 monoclonal antibodies and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025520692A JP2025520692A (ja) | 2025-07-03 |
| JP2025520692A5 true JP2025520692A5 (enExample) | 2026-04-20 |
Family
ID=89379184
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024575463A Pending JP2025520692A (ja) | 2022-06-22 | 2023-06-21 | 抗ｓｌｃ３４ａ２モノクローナル抗体およびその使用 |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US12215150B2 (enExample) |
| EP (1) | EP4543926A1 (enExample) |
| JP (1) | JP2025520692A (enExample) |
| KR (1) | KR20250051643A (enExample) |
| CN (1) | CN119948054A (enExample) |
| AU (1) | AU2023289743A1 (enExample) |
| CA (1) | CA3260354A1 (enExample) |
| CL (1) | CL2024004012A1 (enExample) |
| CO (1) | CO2024017740A2 (enExample) |
| IL (1) | IL317849A (enExample) |
| MX (1) | MX2025000053A (enExample) |
| TW (1) | TW202409076A (enExample) |
| WO (1) | WO2023246879A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025131025A1 (en) * | 2023-12-21 | 2025-06-26 | Lanova Medicines Development Co., Ltd. | Conjugates of anti-slc34a2 antibody and uses thereof |
| CN120988123B (zh) * | 2025-10-21 | 2026-03-17 | 苏州近岸蛋白质科技股份有限公司 | 一种抗人NaPi2b的人源化单克隆抗体及其应用 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8603474B2 (en) | 2008-01-29 | 2013-12-10 | Ludwig Institute For Cancer Research, Ltd. | Membrane transporter NaPi2b (SCL34A1) epitope for antibody therapy, antibodies directed thereto, and target for cancer therapy |
-
2023
- 2023-06-21 TW TW112123436A patent/TW202409076A/zh unknown
- 2023-06-21 CN CN202380053616.2A patent/CN119948054A/zh active Pending
- 2023-06-21 WO PCT/CN2023/101761 patent/WO2023246879A1/en not_active Ceased
- 2023-06-21 KR KR1020257001435A patent/KR20250051643A/ko active Pending
- 2023-06-21 IL IL317849A patent/IL317849A/en unknown
- 2023-06-21 JP JP2024575463A patent/JP2025520692A/ja active Pending
- 2023-06-21 CA CA3260354A patent/CA3260354A1/en active Pending
- 2023-06-21 AU AU2023289743A patent/AU2023289743A1/en active Pending
- 2023-06-21 EP EP23826524.3A patent/EP4543926A1/en active Pending
-
2024
- 2024-05-06 US US18/656,092 patent/US12215150B2/en active Active
- 2024-12-23 CL CL2024004012A patent/CL2024004012A1/es unknown
- 2024-12-23 CO CONC2024/0017740A patent/CO2024017740A2/es unknown
-
2025
- 2025-01-06 MX MX2025000053A patent/MX2025000053A/es unknown
- 2025-01-14 US US19/019,784 patent/US20250154248A1/en active Pending